What it sells
Early, pain-free cancer detection.
Business model breakdown
Buyer: who owns the budget?
Hospital pathology/cytology labs and reference labs; distributors and OEM partners.
Trigger: what makes them buy now?
Need same-day cytology results instead of two days of cell blocks and serial stains.
Workflow: what inputs become what output?
Cytocentrifuge sample to one slide, cryofix, multiplex stain seven markers automatically, digital review in under 4 hours (3 h 23 min vs 38 h 46 min).
Economics: what it saves and how it charges
Instrument placement plus recurring Cryophore panels and reagents; also OEM/lab services.
Distribution: how it reaches customers
Demo requests, online catalogue/order, distributors, KOL/reference sites; in routine use at German hospital labs.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2015 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.